General Information of Drug (ID: DM8T6H7)

Drug Name
ALN-HTT Drug Info
Indication
Disease Entry ICD 11 Status REF
Huntington disease 8A01.10 Preclinical [1]
Cross-matching ID
TTD Drug ID
DM8T6H7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Huntingtin gene antisense DM3NP4I Huntington disease 8A01.10 Preclinical [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Huntingtin messenger RNA (HTT mRNA) TTIWZ0O HD_HUMAN Not Available [1]

References

1 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).
2 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.